The myeloid mineralocorticoid receptor regulates dermal angiogenesis and inflammation in glucocorticoid-induced impaired wound healing.
Van Tuan NguyenQui Trung NgoRoberto Palacios RamirezToshifumi NakamuraNicolette FarmanSelim AractingiFrédéric JaisserPublished in: British journal of pharmacology (2022)
Topical MR antagonism facilitates the switching of macrophages towards an anti-inflammatory phenotype, which improves prolonged inflammation and induces angiogenesis to accelerate wound healing delayed by glucocorticoid treatment.